Abstract
There is a lack of consensus regarding optimal lung cancer screening (LCS) intervals. Shorter intervals are more likely to detect early stage (curable) cancers at the cost of increased low-dose computed tomography (LDCT) resource, financial costs, and more invasive tests. Annual screening is recommended in the USA, whilst biennial screening is recommended in England’s Targeted Lung Health Check (TLHC) programme for those with an entirely negative baseline scan. Risk prediction models (RPMs) for lung cancer risk are used to determine screening eligibility.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
